Zhang, T., Tidwell, R. S., Zhang, S., Qin, Q., Cole, S., Msaouel, P., Hahn, A. W., Shah, A. Y., Campbell, M. T., Jiang, C., Vento, J., Courtney, K. D., Brugarolas, J., Wood, L. M., Issa, W., Kaur, N., Wang, A. Z., Tannir, N. M., Hammers, H. J., Jonasch, E. (2026). A phase II study bolstering outcomes by optimizing immunotherapy strategies with evolocumab and nivolumab in patients with metastatic renal cell carcinoma (BOOST-RCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps581